SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-026165
Filing Date
2022-07-18
Accepted
2022-07-15 20:16:36
Documents
12
Period of Report
2022-07-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K brhc10039716_8k.htm   iXBRL 8-K 22205
  Complete submission text file 0001140361-22-026165.txt   156317

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ions-20220715.xsd EX-101.SCH 3932
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20220715_lab.xml EX-101.LAB 22544
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20220715_pre.xml EX-101.PRE 16048
6 EXTRACTED XBRL INSTANCE DOCUMENT brhc10039716_8k_htm.xml XML 4056
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 221087947
SIC: 2834 Pharmaceutical Preparations